Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Revenues:
Product sales		$ 530
Total revenues		530
Cost of revenues:
Product sales		212
Total cost of revenues		212
Gross margin		318
Operating expenses:
Research and development expenses	132,962	199,599
Selling, general and administrative expenses	433,193	355,327
Total operating expenses	566,155	554,926
Operating loss	(566,155)	(554,608)
Other income (expense):
Gain on debt conversion		15,220
Change in fair value of derivatives	4,217	44,096
Interest expense	(103,366)	(155,555)
Debt Forgiveness Income	42,702
Net loss	(622,602)	(650,847)
Preferred stock dividend	(32,390)	(30,851)
Net loss applicable to common shareholders	$ (654,992)	$ (681,698)
Basic and diluted net loss per average share available to common shareholders (in Dollars per share)	$ (0.01)	$ (0.01)
Weighted average common shares outstanding – basic and diluted (in Shares)	73,443,558	73,367,810